The short version
IvyRx is a flat-rate telehealth provider. It has no rankable price in our database as of September 4, 2026; it is listed so the candidate universe is complete. Verification status: unverified.
The numbers, plan by plan
- Tirzepatide (standard, month-to-month plan): no rankable price. "Starts at $175" with terms unclear per the source; tirzepatide-specific pricing must be confirmed with the provider before it can be recorded.
Fees and what the price includes
Shipping is included. The clinician consultation is included. The price does not change with dose.
How this pricing structure plays out over a year
Because IvyRx has no rankable price, the structure below is what a patient should expect to reconstruct from its checkout: the recurring medication price at the starting and highest dose, any membership or program fee and its introductory rate, the plan length behind any headline figure, and what happens to the price at renewal. Until those are published or captured, the twelve-month cost cannot be stated, and we do not guess it.
Compared with the field
IvyRx is not ranked, so it has no position in the field; it will enter the ranking automatically when a price is verified.
Pharmacy, coverage and cancellation
A complete list of states served has not been published; confirm eligibility at checkout before paying. Dispensing: Named partner pharmacies including a 503B partner alongside 503A partners (per the source); roster not captured. Commitment: month-to-month available; longer terms discount the rate. Cancellation: not captured.
Questions to ask IvyRx before paying
Ask, in writing: Do you ship to my state, and which pharmacy license covers it? Which pharmacy fills the prescription, is it 503A or 503B, and can I see a certificate of analysis for my batch? How do I cancel, how much notice is required, and is there a fee? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
Names its partner pharmacies and references a 503B partner with USP <797>/CGMP standards, per the source.
What to weigh against it
Pricing terms unclear; website not recorded.
Who should choose IvyRx
Patients prioritizing a disclosed 503B pharmacy who confirm the price in writing. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
Is IvyRx legitimate? What we can verify
IvyRx operates as a telehealth prescriber: a licensed clinician reviews an intake and issues a prescription, and a pharmacy fills it. That is the lawful model, and it is the same model every provider on this site uses; the questions that separate a legitimate operation from a risky one are whether the price is published before intake, whether the pharmacy is named, whether the prescription documents a clinical reason for a compounded product, and whether the company answers questions in writing. Its prices could not be pinned down from its own pages, which is a transparency failure rather than evidence of wrongdoing. It does not publicly name its dispensing pharmacy, so a patient cannot verify the license without asking. We have no evidence of a scam, and we do not use the word for any provider that prescribes on a valid prescription and ships from a licensed pharmacy; LegitScript certification, BBB profiles and state-board actions are not yet captured in our data and are listed as checks a patient can make.
IvyRx complaints and reputation
We have not yet analyzed public reviews of IvyRx for complaint patterns; the reputation index explains the method (shipping, billing and refund, provider access, support, and dosing-instruction complaints as shares of recent reviews). Until it is run, the useful checks are Trustpilot and the Better Business Bureau for volume and recency, and Reddit threads for the specific failure modes patients describe: shipments that arrive warm, charges after cancellation, clinicians who do not answer, and dosing sheets that do not match the vial.
Fees, HSA/FSA and promotions
No introductory or promotional price is recorded; we do not publish promotional codes. HSA/FSA eligibility is not captured; most telehealth GLP-1 programs can issue itemized receipts for FSA/HSA reimbursement, but eligibility of compounded medication depends on the plan administrator. The consultation is included in the price.
Consultation, labs, refills and shipping
Consultation type (video, phone or asynchronous questionnaire) is not captured in our data; most compounded-GLP-1 telehealth intakes are asynchronous with a clinician follow-up, and a patient who needs a video visit should ask. Lab requirements are not captured; many providers accept recent labs and some require none for compounded GLP-1s, while brand-name and insurance-first programs more often require them. Refill process is not captured; ask how a dose increase is requested, how many days before the next dose a refill ships, and whether a new visit is required. Shipping is included; transit is typically one to three days by carrier after the pharmacy fills.
Alternatives to IvyRx
Alternatives worth comparing: NexLife has the highest value score for tirzepatide (92) at $1,668 for twelve months; Trimi has the lowest twelve-month total ($1,500, verified). Side-by-side: IvyRx vs NexLife.
Update history
No price changes or corrections have been logged for IvyRx since tracking began on August 25, 2026. Any future change appears on the price history page with the date, old figure, new figure and source.
How we verified this
Cited by Policy Lab as starting at $175 with unclear terms and as the clearest 503B-partner option on its list; unranked pending a captured price and domain. Reported from Policy Lab's 'Best Online Tirzepatide Compounding Providers Compared For 2026' (updated August 19, 2026); direct first-party verification pending.